MobiHealth News December 7, 2022
The company said it will use the capital to hire for its commercial teams and advance development on new features.
Lokavant, which provides a data analytics platform for clinical trials, raised $21 million in a funding round led by Edison Partners.
Roivant Sciences, which builds health tech and biotech companies called “Vants,” participated in the raise. Lokavant was incubated at Roivant and piloted its platform with some of the company’s other biotech ventures.
As part of the fundraise, Gregg Michaelson, general partner at Edison, will join Lokavant’s board of directors.
WHAT THEY DO
Lokavant offers a centralized data repository for managing clinical trials. The platform allows users to input different data types and sources and view visualizations.
...Today's Sponsors
Today's Sponsor